PARP Inhibitors for BRCA1/2-mutated and Sporadic Ovarian Cancer: Current Practice and Future Directions
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.311
Full Text
Open PDFAbstract
Available in full text
Date
October 13, 2016
Authors
Publisher
Springer Science and Business Media LLC